María Cristina Faingold

Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial

Stephen C. Bain, Ofri Mosenzon, Rosario Arechavaleta et al. · Diabetes Obesity and Metabolism · 2018 · 97 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

PPAR activation as a regulator of lipid metabolism, nitric oxide production and lipid peroxidation in the placenta from type 2 diabetic patients

Evangelina Capobianco, Nora Martínez, Daiana Fornes et al. · Molecular and Cellular Endocrinology · 2013 · 43 citations · Full text

Life Sciences, Biochemistry, Obstetrics +17

Regulation of Matrix Metalloproteinases 2 and 9 Activities by Peroxynitrites in Term Placentas From Type 2 Diabetic Patients

Evangelina Capobianco, Verónica White, M. Sosa et al. · Reproductive Sciences · 2012 · 23 citations · Full text

Life Sciences, Biochemistry, Obstetrics +13

Myxedema madness complicating postoperative follow-up of thyroid cancer

Yanina Jimena Morosan Allo, Melanie Rosmarin, Agustina Urrutia et al. · Archives of Endocrinology and Metabolism · 2015 · 14 citations · Full text

Medicine, Endocrinology, Surgery +17

Intranasal Insulin Administration in Insulin Dependent Diabetes:

Isaac Sinay, S Schlimovich, S Damilano et al. · Hormone and Metabolic Research · 1990 · 13 citations

Medicine, Endocrinology, Internal Medicine +6